Navigation Links
Prostate Cancer Treatment Offers Results Without Side Effects

SARASOTA, Fla., May 28 /PRNewswire/ -- Mike Strong, a health minister for Hallelujah Acres, was only 52 when an annual physical revealed his Prostate Specific Antigen (PSA) was 31 (normal is 4 or under). Although he had no symptoms, a biopsy confirmed that he had cancer.

His doctor urged him to have a radical prostectomy to remove his prostate and surrounding tissue. He refused, but did agree to take the testosterone blocker Lupron for one year.

The Lupron made him feel extremely tired and he lost all sexual desire. The drug temporarily lowered his PSA, but it jumped to 46 when he stopped it.

Mike began researching treatments that would not cause impotence (erectile dysfunction), incontinence (urine leakage) or a host of other side effects. He went on a raw food diet, had his dental amalgams removed and took testosterone blockers, which also eliminated his libido. He joined a clinical trial, but his cancer began to spread and he lost an alarming amount of weight.

While taking part in the clinical trial, Mike met Dr. Antonio Jimenez, Medical Director of the Hope4Cancer Institute in Baja, California. "Dr. Jimenez offered a non-toxic, proven cancer treatment that combined Sono-Photo Dynamic Therapy with radio-wave hyperthermia. Finally, a treatment without side effects!"

As early as age 40, the prostate may begin to increase in size, and by age sixty, 80% of men have an enlarged prostate. This can cause the urethra to narrow, decreasing urine flow. Symptoms include an urgent need to urinate (especially at night), a thin stream, discomfort above the bladder, blood in the urine, low back pain, weak or interrupted flow and pain or burning when urinating. Sometimes, prostate cells begin to grow abnormally, forming a tumor.

Prostate screening normally includes a blood test called PSA, digital rectal exam (DRE) and a Sonogram/Ultrasound. If cancer is suspected, traditional medicine requires a biopsy where a Gleason score (a system of grading tissue/aggressiveness after biopsy) is obtained, followed by surgery and some combination of radiation, chemotherapy and hormone therapy. Seed radiation or brachytherapy is another invasive procedure where tiny 'seeds' are implanted that deliver a time-release dose of radiation. Side effects of these treatments often leave a man with impotence, incontinence, fatigue, hot flashes, rectal irritation or damage, diarrhea and blood in the stool. At least 40% of all surgery patients will experience erectile dysfunction. Side effects may not be apparent immediately; they can begin gradually and increase with time in the years after treatment.

According to the National Cancer Institute, 218,890 men were diagnosed with prostate cancer in the United States in 2007. Understandably, men are horrified at the thought of becoming impotent and incontinent. Since virtually all treatments offered in the USA come with a host of undesirable side effects, many patients like Mike Strong are seeking treatments outside the United States.

Strong traveled to Baja to the Hope4Cancer Institute, a small 'boutique' clinic with 5 patient rooms and 5 physicians on staff. "I arrived in a wheelchair, and I had a catheter," Mike explained. "After a week of treatment, I was playing golf and have not worn a catheter since."

According to Dr. Jimenez, after two weeks of treatment Mike's sonogram showed a 50% decrease in tumor size and his blood work was normal. "In my 20 years of medical practice, Sono-Photo Dynamic Therapy (SPDT) is the most effective treatment for Prostate cancer that I have ever offered. It gives patients improved quality of life while attacking cancer cells and tumors."

Mike received Sono-Photo Dynamic Therapy (SPDT). During this treatment patients ingest a chlorophyll-like agent that adheres to cancer cells. Then, sound (sono) and light (photo) are pulsed through the body at very precise frequencies that cause the agent to 'explode' with free radical oxygen, instantly killing cancer cells, which cannot survive in the presence of oxygen. SPDT has just recently been approved in the US, although it has been used in other countries since the 1800's.

In addition, he received radio-wave hyperthermia, a treatment that heats cancer cells and damages them so they cannot reproduce, without harming normal cells. Other treatments included natural medicines and therapies to kill cancer cells, detoxify the body and build the immune system.

"The treatment was pain-free and had no side effects, and I just kept feeling better and better," Mike says. "Patients owe it to themselves to look at all their options."

Patient name has been changed to protect his privacy. Marla Manhart is a health writer and cancer patient advocate. She can be reached at .

SOURCE Hope4Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. New Gene Methylation Test for Prostate Cancer Available
2. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
3. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
4. Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Mens Health Week Is June 9-15)
5. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
6. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
7. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
8. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
9. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
10. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
11. Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Advanced Wound Care Market by Type ... Ulcers), End User (In-Patient Facility, Out-Patient Facility), and Geography ... offering. --> --> ... the description, definition and forecast of the global advanced ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released a ... Mesothelioma has just posted the findings on the website. Click here to read ... of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College ... Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD ... colleges, as only one of twelve colleges and universities in the state of California ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
Breaking Medicine News(10 mins):